Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024Marine Maurel, Ralf Dürrwald, Goranka Petrović et al.|Eurosurveillance|2024Cited by 50
Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre studyMarine Maurel, Francisco Pozo, Gloria Pérez‐Gimeno et al.|Influenza and Other Respiratory Viruses|2024Cited by 28
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024Charlotte Lanièce Delaunay, Esther Kissling, Aryse Melo et al.|Vaccine|2024Cited by 24
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022Charlotte Lanièce Delaunay, Iván Martínez‐Baz, Noémie Sève et al.|Eurosurveillance|2024Cited by 11
Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24Esther Kissling, Marine Maurel, Francisco Pozo et al.|Eurosurveillance|2025Cited by 9